KR880013556A - 도파민수용체 효능제의 용도 - Google Patents
도파민수용체 효능제의 용도 Download PDFInfo
- Publication number
- KR880013556A KR880013556A KR1019880005250A KR880005250A KR880013556A KR 880013556 A KR880013556 A KR 880013556A KR 1019880005250 A KR1019880005250 A KR 1019880005250A KR 880005250 A KR880005250 A KR 880005250A KR 880013556 A KR880013556 A KR 880013556A
- Authority
- KR
- South Korea
- Prior art keywords
- pharmaceutical composition
- dopamine receptor
- nicotine addiction
- receptor agonist
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000003136 dopamine receptor stimulating agent Substances 0.000 title claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 206010057852 Nicotine dependence Diseases 0.000 claims 5
- 208000025569 Tobacco Use disease Diseases 0.000 claims 5
- 229940098778 Dopamine receptor agonist Drugs 0.000 claims 3
- 241000208125 Nicotiana Species 0.000 claims 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 239000013543 active substance Substances 0.000 claims 2
- OZVBMTJYIDMWIL-AYFBDAFISA-N bromocriptine Chemical group C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=C(Br)NC3=C1 OZVBMTJYIDMWIL-AYFBDAFISA-N 0.000 claims 2
- 229960002802 bromocriptine Drugs 0.000 claims 2
- 150000003839 salts Chemical group 0.000 claims 2
- 239000012458 free base Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4775387A | 1987-05-07 | 1987-05-07 | |
| US07/047,753 | 1987-05-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR880013556A true KR880013556A (ko) | 1988-12-21 |
Family
ID=21950776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019880005250A Ceased KR880013556A (ko) | 1987-05-07 | 1988-05-06 | 도파민수용체 효능제의 용도 |
Country Status (13)
| Country | Link |
|---|---|
| JP (1) | JPS63287723A (enExample) |
| KR (1) | KR880013556A (enExample) |
| AU (1) | AU622614B2 (enExample) |
| CH (1) | CH675834A5 (enExample) |
| DE (1) | DE3814521A1 (enExample) |
| DK (1) | DK245388A (enExample) |
| FR (1) | FR2614789B1 (enExample) |
| GB (1) | GB2204240B (enExample) |
| IT (1) | IT1219564B (enExample) |
| NL (1) | NL8801171A (enExample) |
| PH (1) | PH25495A (enExample) |
| SE (1) | SE8801708L (enExample) |
| ZA (1) | ZA883237B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4797405A (en) * | 1987-10-26 | 1989-01-10 | Eli Lilly And Company | Stabilized pergolide compositions |
| DE19626621A1 (de) * | 1996-07-02 | 1998-01-08 | Hexal Ag | Pflaster zur transdermalen Anwendung von Pergolid |
| US6623752B1 (en) | 1996-07-02 | 2003-09-23 | Hexal Ag | Patch for transdermal application for pergolid |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR861128B (en) * | 1985-05-06 | 1986-08-26 | Sandoz Ag | New use of dopamine agonists |
| DE3722383A1 (de) * | 1986-07-14 | 1988-01-28 | Sandoz Ag | Neue verwendung von bromocriptin |
-
1988
- 1988-04-29 DE DE3814521A patent/DE3814521A1/de not_active Withdrawn
- 1988-05-02 FR FR888805957A patent/FR2614789B1/fr not_active Expired - Lifetime
- 1988-05-03 IT IT47906/88A patent/IT1219564B/it active
- 1988-05-04 CH CH1664/88A patent/CH675834A5/de not_active IP Right Cessation
- 1988-05-04 NL NL8801171A patent/NL8801171A/nl not_active Application Discontinuation
- 1988-05-04 GB GB8810509A patent/GB2204240B/en not_active Expired - Lifetime
- 1988-05-05 DK DK245388A patent/DK245388A/da not_active Application Discontinuation
- 1988-05-05 AU AU15605/88A patent/AU622614B2/en not_active Expired - Fee Related
- 1988-05-05 ZA ZA883237A patent/ZA883237B/xx unknown
- 1988-05-05 SE SE8801708A patent/SE8801708L/ not_active Application Discontinuation
- 1988-05-06 JP JP63109280A patent/JPS63287723A/ja active Pending
- 1988-05-06 PH PH36895A patent/PH25495A/en unknown
- 1988-05-06 KR KR1019880005250A patent/KR880013556A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| SE8801708L (sv) | 1988-11-08 |
| FR2614789B1 (fr) | 1991-10-18 |
| SE8801708D0 (sv) | 1988-05-05 |
| ZA883237B (en) | 1990-01-31 |
| NL8801171A (nl) | 1988-12-01 |
| DK245388D0 (da) | 1988-05-05 |
| DK245388A (da) | 1988-11-08 |
| GB8810509D0 (en) | 1988-06-08 |
| IT1219564B (it) | 1990-05-18 |
| AU1560588A (en) | 1988-11-10 |
| GB2204240A (en) | 1988-11-09 |
| CH675834A5 (enExample) | 1990-11-15 |
| GB2204240B (en) | 1991-04-24 |
| FR2614789A1 (fr) | 1988-11-10 |
| IT8847906A0 (it) | 1988-05-03 |
| PH25495A (en) | 1991-07-24 |
| DE3814521A1 (de) | 1988-11-17 |
| AU622614B2 (en) | 1992-04-16 |
| JPS63287723A (ja) | 1988-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2164040T1 (es) | Uso de agonistas del sitio de union de la glicina o de inhibidores de la absorcion de la glicina para el tratamiento de trastornos neuropsiquiatricos. | |
| KR900701282A (ko) | 심장 또는 뇌의 허혈성 질환의 치료, 예방제 | |
| KR920702216A (ko) | 아세틸 d-카르니틴의 녹내장 치료에의 용도 | |
| KR900700089A (ko) | 전신성 피부 투과적 투여를 위한 약학적 조성물 | |
| KR970009799A (ko) | 물질 남용 금단의 치료 방법 | |
| KR930702000A (ko) | 노년기 치매, 식용항진, 편두통, 또는 식용불량의 치료를 위한 파로세틴의 사용 | |
| KR880002515A (ko) | 흡수 및 작용이 빠른 설린다크 또는 나트륨 설린다크와 염기의 혼합물 | |
| KR920703041A (ko) | 통증을 수반하는 염증성 또는 알레르기성 질환치료에 사용되는 성분물과 그 방법 | |
| CA2270955A1 (en) | Pharmaceutical composition containing morphinan derivative for treating drug dependence | |
| KR970025615A (ko) | 암 전이 억제제 | |
| WO2002034267A8 (de) | Kombination eines transdermalen therapeutischen systems und einer oralen und/oder parenteralen zubereitung enthaltend dopaminagonisten zur behandlung dopaminerger erkrankungen | |
| KR880007073A (ko) | 의 약 품 | |
| KR900016135A (ko) | 피부 및 점막-상피의 질환 치료용 4-퀴놀린 카복실산 유도체 | |
| KR830002510A (ko) | 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물 | |
| BR0211855A (pt) | Medicamento e método para tratamento e melhoria da qualidade restauradora do sono | |
| KR950701922A (ko) | 치환된 트리아졸의 설페이트 염, 이를 포함하는 약제학적 조성물 및 치료요법에서의 이의 용도(The sulphate salt of a substituted triazole, pharmaceutical compositions thereof and their use in therapy) | |
| KR880013556A (ko) | 도파민수용체 효능제의 용도 | |
| MX9203361A (es) | Composiciones farmaceuticas que contienen cloruro de galio. | |
| KR920702225A (ko) | 약학 조성물 | |
| KR970701191A (ko) | 복소환 화합물 | |
| US4476115A (en) | Analgesic composition and method of treating subdermal pain | |
| KR880004810A (ko) | 소화성 궤양 치료제 | |
| KR910004190A (ko) | 온단세트론의 신규 의학 용도 | |
| KR890007728A (ko) | 진통제 제조방법 | |
| KR900017599A (ko) | 종양 치료용 약학 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19880506 |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19930506 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19880506 Comment text: Patent Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19961007 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 19970210 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 19961007 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |